Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials.

These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Tardive Dyskinesia Central Nervous System Diseases Dyskinesia, Drug-Induced Dyskinesias Movement Disorders Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of tardive dyskinesia
Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
No prior treatment for tardive dyskinesia

Exclusion criteria

Enrolled in another research study
Inability to provide written informed consent
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Treatment and study plan

Primary outcomes

Rate of patients who decide to enroll in a tardive dyskinesia clinical research.

Time frame: 3 months
Number of tardive dyskinesia study participants who remain in clinical study until completion.

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

4159004227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Examining Engagement Patterns: An Observational Exploration About Tardive Dyskinesia Clinical Trials

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2027
First posted: Jan 23, 2024
Registry last updated: Jan 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting